Bollard Group LLC Boston Scientific Corp Transaction History

Bollard Group LLC

$3.31 Billion
Q1 2024

A detailed history of Bollard Group LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Bollard Group LLC holds 21,998,621 shares of BSX stock, worth $1.66 Billion. This represents 45.57% of its overall portfolio holdings.

Number of Shares

21,998,621

Previous 22,391,511 1.75%

Holding current value

$1.66 Billion

Previous $1.29 Billion 16.4%

% of portfolio

45.57%

Previous 45.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$57.6 - $68.62 $22.6 Million - $27 Million	-392,890 Reduced 1.75%	21,998,621 $1.51 Billion
Q4 2023 Feb 13, 2024	SELL	$48.64 - $57.81 $46.4 Million - $55.1 Million	-953,215 Reduced 4.08%	22,391,511 $1.29 Billion
Q3 2023 Nov 14, 2023	SELL	$50.19 - $54.68 $16.6 Million - $18.1 Million	-330,355 Reduced 1.4%	23,344,726 $1.23 Billion
Q2 2023 Aug 14, 2023	SELL	$49.72 - $54.64 $21.5 Million - $23.6 Million	-432,545 Reduced 1.79%	23,675,081 $1.28 Billion
Q1 2023 May 12, 2023	SELL	$45.09 - $50.03 $15.9 Million - $17.7 Million	-353,200 Reduced 1.44%	24,107,626 $1.21 Billion

Q4 2022 Feb 10, 2023	SELL	$39.56 - $47.22 $50.6 Million - $60.4 Million	-1,278,765 Reduced 4.97%	24,460,826 $1.13 Billion
Q3 2022 Nov 09, 2022	SELL	$36.71 - $109.66 $16.8 Million - $50 Million	-456,400 Reduced 1.74%	25,739,591 $997 Million
Q2 2022 Aug 12, 2022	SELL	$35.24 - $47.1 $15.4 Million - $20.6 Million	-437,881 Reduced 1.64%	26,195,991 $976 Million
Q1 2022 May 12, 2022	SELL	$40.9 - $45.1 $13.5 Million - $14.9 Million	-329,826 Reduced 1.22%	26,633,872 $1.18 Billion
Q4 2021 Feb 11, 2022	SELL	$38.07 - $44.87 $7.36 Million - $8.67 Million	-193,215 Reduced 0.71%	26,963,698 $1.15 Billion
Q3 2021 Nov 12, 2021	SELL	$41.23 - $45.88 $108 Million - $121 Million	-2,628,079 Reduced 8.82%	27,156,913 $1.18 Billion
Q2 2021 Aug 12, 2021	SELL	$38.58 - $44.24 $61.3 Million - $70.3 Million	-1,590,099 Reduced 5.07%	29,784,992 $1.27 Billion
Q1 2021 May 11, 2021	BUY	$35.27 - $39.67 $2.73 Million - $3.07 Million	77,380 Added 0.25%	31,375,091 $1.21 Billion
Q4 2020 Feb 04, 2021	SELL	$33.15 - $41.97 $24.1 Million - $30.5 Million	-727,250 Reduced 2.27%	31,297,711 $1.13 Billion
Q3 2020 Nov 12, 2020	SELL	$34.44 - $42.23 $13.4 Million - $16.4 Million	-389,132 Reduced 1.2%	32,024,961 $1.22 Billion
Q2 2020 Aug 13, 2020	SELL	$30.19 - $39.11 $7.58 Million - $9.81 Million	-250,945 Reduced 0.77%	32,414,093 $1.14 Billion
Q1 2020 May 14, 2020	SELL	$25.83 - $45.71 $12.5 Million - $22.1 Million	-483,945 Reduced 1.46%	32,665,038 $1.07 Billion
Q4 2019 Feb 10, 2020	SELL	$37.87 - $45.37 $8.47 Million - $10.1 Million	-223,605 Reduced 0.67%	33,148,983 $1.5 Billion
Q3 2019 Nov 13, 2019	SELL	$40.31 - $43.45 $5.82 Million - $6.27 Million	-144,338 Reduced 0.43%	33,372,588 $1.36 Billion
Q2 2019 Aug 13, 2019	SELL	$34.91 - $42.98 $2.28 Million - $2.8 Million	-65,200 Reduced 0.19%	33,516,926 $1.44 Billion
Q4 2018 Feb 05, 2019	BUY	$31.73 - $39.04 $444,220 - $546,560	14,000 Added 0.04%	33,582,126 $1.19 Billion
Q3 2018 Nov 08, 2018	BUY	$32.83 - $38.63 $1.86 Million - $2.19 Million	56,622 Added 0.17%	33,568,126 $1.29 Billion
Q2 2018 Aug 09, 2018	SELL	$26.84 - $34.32 $3.85 Million - $4.93 Million	-143,537 Reduced 0.43%	33,511,504 $1.1 Billion
Q1 2018 May 14, 2018	SELL	$25.2 - $28.54 $5.02 Million - $5.68 Million	-199,076 Reduced 0.59%	33,655,041 $919 Million
Q4 2017 Jan 29, 2018	BUY	$24.79 - $29.8 $2.93 Million - $3.52 Million	118,050 Added 0.35%	33,854,117 $839 Million
Q3 2017 Oct 27, 2017	BUY	$26.26 - $29.17 $886 Million - $984 Million	33,736,067	33,736,067 $984 Million

Others Institutions Holding BSX

# of Institutions

1,319

Shares Held

1.17B

Call Options Held

5.92M

Put Options Held

5.75M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $108B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bollard Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bollard Group LLC with notifications on news.

Account

Bollard Group LLC Boston Scientific Corp Transaction History